149 related articles for article (PubMed ID: 31578341)
1. Synthetic PreImplantation Factor (sPIF) induces posttranslational protein modification and reverses paralysis in EAE mice.
Hayrabedyan S; Shainer R; Yekhtin Z; Weiss L; Almogi-Hazan O; Or R; Farnsworth CL; Newsome S; Todorova K; Paidas MJ; Brodie C; Barnea ER; Mueller M
Sci Rep; 2019 Oct; 9(1):12876. PubMed ID: 31578341
[TBL] [Abstract][Full Text] [Related]
2. Preimplantation factor (PIF*) reverses neuroinflammation while promoting neural repair in EAE model.
Weiss L; Or R; Jones RC; Amunugama R; JeBailey L; Ramu S; Bernstein SA; Yekhtin Z; Almogi-Hazan O; Shainer R; Reibstein I; Vortmeyer AO; Paidas MJ; Zeira M; Slavin S; Barnea ER
J Neurol Sci; 2012 Jan; 312(1-2):146-57. PubMed ID: 21996270
[TBL] [Abstract][Full Text] [Related]
3. PIF* promotes brain re-myelination locally while regulating systemic inflammation- clinically relevant multiple sclerosis M.smegmatis model.
Migliara G; Mueller M; Piermattei A; Brodie C; Paidas MJ; Barnea ER; Ria F
Oncotarget; 2017 Mar; 8(13):21834-21851. PubMed ID: 28423529
[TBL] [Abstract][Full Text] [Related]
4. PreImplantation Factor bolsters neuroprotection via modulating Protein Kinase A and Protein Kinase C signaling.
Mueller M; Schoeberlein A; Zhou J; Joerger-Messerli M; Oppliger B; Reinhart U; Bordey A; Surbek D; Barnea ER; Huang Y; Paidas M
Cell Death Differ; 2015 Dec; 22(12):2078-86. PubMed ID: 25976303
[TBL] [Abstract][Full Text] [Related]
5. Synthetic PreImplantation Factor (sPIF) reduces inflammation and prevents preterm birth.
Spinelli M; Boucard C; Di Nicuolo F; Haesler V; Castellani R; Pontecorvi A; Scambia G; Granieri C; Barnea ER; Surbek D; Mueller M; Di Simone N
PLoS One; 2020; 15(6):e0232493. PubMed ID: 32511256
[TBL] [Abstract][Full Text] [Related]
6. Disease modifying mitochondrial uncouplers, MP101, and a slow release ProDrug, MP201, in models of Multiple Sclerosis.
Bando Y; Geisler JG
Neurochem Int; 2019 Dec; 131():104561. PubMed ID: 31585135
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis.
Schmitz K; Brunkhorst R; de Bruin N; Mayer CA; Häussler A; Ferreiros N; Schiffmann S; Parnham MJ; Tunaru S; Chun J; Offermanns S; Foerch C; Scholich K; Vogt J; Wicker S; Lötsch J; Geisslinger G; Tegeder I
Acta Neuropathol Commun; 2017 Jun; 5(1):42. PubMed ID: 28578681
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
Ramroodi N; Khani M; Ganjali Z; Javan MR; Sanadgol N; Khalseh R; Ravan H; Sanadgol E; Abdollahi M
Immunol Invest; 2015; 44(7):694-712. PubMed ID: 26436854
[TBL] [Abstract][Full Text] [Related]
9. The Use of Agmatine Provides the New Insight in an Experimental Model of Multiple Sclerosis.
Ninkovic M; Stevanovic I; Stojanovic I; Ljubisavljevic S; Basic J; Peric P
Neurochem Res; 2015 Aug; 40(8):1719-27. PubMed ID: 26141226
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
Kanwar JR; Kanwar RK; Krissansen GW
Brain; 2004 Jun; 127(Pt 6):1313-31. PubMed ID: 15130951
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.
Shaw MA; Gao Z; McElhinney KE; Thornton S; Flick MJ; Lane A; Degen JL; Ryu JK; Akassoglou K; Mullins ES
J Neurosci; 2017 Apr; 37(14):3776-3788. PubMed ID: 28275164
[TBL] [Abstract][Full Text] [Related]
12. Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
Li-ChunHsieh K; Schob S; Zeller MW; Pulli B; Ali M; Wang C; Chiou TT; Tsang YM; Lee PS; Stossel TP; Chen JW
J Neuroimmunol; 2015 Oct; 287():36-42. PubMed ID: 26439960
[TBL] [Abstract][Full Text] [Related]
13. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
[TBL] [Abstract][Full Text] [Related]
14. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
[TBL] [Abstract][Full Text] [Related]
15. The modulatory effects of luteolin on cyclic AMP/Ciliary neurotrophic factor signaling pathway in experimentally induced autoimmune encephalomyelitis.
El-Deeb OS; Ghanem HB; El-Esawy RO; Sadek MT
IUBMB Life; 2019 Sep; 71(9):1401-1408. PubMed ID: 31185137
[TBL] [Abstract][Full Text] [Related]
16. Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis.
Gerzanich V; Makar TK; Guda PR; Kwon MS; Stokum JA; Woo SK; Ivanova S; Ivanov A; Mehta RI; Morris AB; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2017 Sep; 14(1):177. PubMed ID: 28865458
[TBL] [Abstract][Full Text] [Related]
17. Increased thrombin inhibition in experimental autoimmune encephalomyelitis.
Beilin O; Karussis DM; Korczyn AD; Gurwitz D; Aronovich R; Hantai D; Grigoriadis N; Mizrachi-Kol R; Chapman J
J Neurosci Res; 2005 Feb; 79(3):351-9. PubMed ID: 15605378
[TBL] [Abstract][Full Text] [Related]
18. Absence of system x
Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
[TBL] [Abstract][Full Text] [Related]
19. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
20. High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.
Oxombre B; Lee-Chang C; Duhamel A; Toussaint M; Giroux M; Donnier-Maréchal M; Carato P; Lefranc D; Zéphir H; Prin L; Melnyk P; Vermersch P
Br J Pharmacol; 2015 Apr; 172(7):1769-82. PubMed ID: 25521311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
